Table: Jcr Pharmaceuticals -2025/26 group results

JCR Pharmaceuticals

23/06/2026 08:00

    Jun 23 (Reuters)- 
          Jcr Pharmaceuticals Co., Ltd. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Mar 31, 2026    Mar 31, 2025   Mar 31, 2027     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             40.32           33.07          45.70                 
                 (+21.9 pct)     (-22.9 pct)    (+13.3 pct)              
  Operating        555 mln        loss 6.22         1.10                 
                                                (+98.2 pct)              
  Recurring          1.17         loss 7.05       500 mln                
                                                (-57.1 pct)              
  Net
  Net                2.18         loss 4.46       200 mln                
                                                (-90.8 pct)              
  EPS             17.87 yen    loss 36.02 yen    1.64 yen                
  EPS Diluted     17.86 yen                                              
  Ann Div         20.00 yen       20.00 yen      20.00 yen               
  -Q2 Div         10.00 yen       10.00 yen      10.00 yen               
  -Q4 Div         10.00 yen       10.00 yen      10.00 yen               
  
  NOTE - Jcr Pharmaceuticals Co., Ltd..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4552.T